NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.30 Cr |
What is the latest Cash Flow from Financing Activities ratio of NGL FINECHEM ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.08 Cr |
Mar2023 | ₹-1.08 Cr |
Mar2022 | ₹-1.08 Cr |
Mar2021 | ₹-1.08 Cr |
Mar2020 | ₹-1.30 Cr |
How is Cash Flow from Financing Activities of NGL FINECHEM Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.08 Cr | Negative | |
Mar2023 | ₹-1.08 Cr | Negative | |
Mar2022 | ₹-1.08 Cr | Negative | |
Mar2021 | ₹-1.08 Cr | Negative | |
Mar2020 | ₹-1.30 Cr | - |
Compare Cash Flow from Financing Activities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹812.0 Cr | -4.6% | 32.3% | -47.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -4.6% |
32.3% |
-47.5% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses